Study to Evaluate EB-001 in Reducing Musculoskeletal Pain
Status:
Completed
Trial end date:
2018-08-07
Target enrollment:
Participant gender:
Summary
To determine the safety and efficacy of single intra-operative treatment of EB-001 IM
injections into the Pectoralis Major (PM) in subjects undergoing breast augmentation with
subpectoral implants